A product named 'Synchron Switch' was developed by the New York-based business Synchron to let patients operate an iPhone or iPad with their minds.

A blood artery is used to inject a 'Stentrode,' an array of sensors, into the top of the brain. From the patient's chest, the Synchron Switch is used to wirelessly operate it.

According to a report, Gorham is the first person to ever use the Synchron Switch device with an Apple product. Six patients of Synchron are currently using it.

Tom Oxley, co-founder and CEO of Synchron, was quoted as saying, 'We're enthusiastic about iOS and Apple devices because they're so pervasive, and this would be the first brain switch input into the device.'

Gorham's suggestions are implemented using the Synchron Switch on the iPad. The iPad recognises Gorham's thought of touching his foot as a finger tap. According to Semafor, Gorham can send one-word texts from his iPad using his Synchron Switch.

Synchron is the first business to have its clinical studies for a computer-brain implant approved by the US Food and Drug Administration. The company, which has secured venture capital and other investments totaling $70 million, is responsible for paying for the device's implantation and upkeep, it was stated.